The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Baker McKenzie

100 NEW BRIDGE STREET, LONDON, EC4V 6JA, ENGLAND
Tel:
Work 020 7919 1000
Fax:
Fax 020 7919 1999
DX:
233 LONDON CHANCERY LANE WC2
Email:
Web:
www.bakermckenzie.com

Hiroshi Sheraton

Tel:
Work 020 7919 1889
Email:
Baker McKenzie LLP

Work Department

Intellectual property.

Position

Hiroshi Sheraton's practice covers all aspects of intellectual property law with a particular emphasis on contentious patent and trade mark matters and life sciences. Much of his work is cross-border in nature. He regularly co-ordinates pan-European and global IP litigation and advises clients on international IP strategies for patent litigation and brand protection. He represents clients in the UKIPO, EPO, OHIM, the English Courts and the CJEU. He has experience of IP matters across Europe and has litigated IP cases in Germany, France, Spain, Italy, the Netherlands, Belgium, Austria, Ireland, Northern Ireland and Luxembourg, the USA and Asia Pacific. Although he has a first degree in biochemistry and molecular biology, he covers all areas of technology from pharmaceuticals/biotech products and agrochemicals to electronics and software. Hiroshi is particularly involved at the interface between IP law and other legal disciplines such as EU competition law. He is currently involved in one of the first "reverse payment" patent settlement cases pending before the European Commission, and has been involved in some of the leading cases concerning "Euro-defences" to IP infringement and abusive assertion of IP rights. He also has experience advising on pharmaceutical regulatory issues where they interact with traditional IP rights such as matters concerning Supplementary Protection Certificates, data exclusivity and clinical trials. In the brand protection arena, Hiroshi assists several household name brands on enforcement and portfolio management issues especially in highly regulated industries such as alcohol beverages and online gaming.

Career

Trained London IP boutique firm, Bristows; solicitor 1999; associate McDermott Will & Emery, 2001; partner 2007; partner Baker McKenzie 2014.

Languages

English

Member

Intellectual Property Association - Member; Institute of Trade Mark Attorneys (ITMA) - Member; Law Society of England & Wales - Member; Chartered Institute of Patent Attorneys - Member

Education

Cambridge University (St. John's College) (M.A. Biochemistry/Molecular Biology) (1995); College of Law (L.P.C.) (1997); College of Law (C.P.E.) (1997); Bristol University (Post Graduate Diploma Intellectual Property Law) (2000)


London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

The 'experienced and professional' practice at Baker McKenzie attracts praise for its 'knowledge of intellectual property and sharp business acumen'. It successfully acted for L'Oréal in several disputes, including a patent and registered community designs right infringement claim against RN Ventures. It also defended the client in a multi-jurisdictional patent dispute brought by Liqwd (Olaplex), relating to a hair treatment. In another work highlight, Michael Hart acted for a fashion retailer in an action relating to the use of confidential information (of an upcoming product launch) to obtain high proportions of new products using automated bot technology. Practice head Michelle Blunt led a team, alongside Hiroshi Sheraton, which is advising a blockchain and bitcoin innovator on protection of IP assets. The group is also instructed by new clients Swarovski, Liberty Mutual, Dropbox and Sanofi-Aventis. Ben Allgrove specialises in contentious and regulatory IP matters 'is sharp and knows how to outwit the other side in a negotiation'. The 'commercial, strategic and responsive' head of brand management, Jessica Le Gros is also highlighted for her 'high-quality service'. Changes to the team include the departures of trade-mark attorney Tom Hooper and senior associate Alex Morgan  to Taylor Wessing LLP and EIP respectively.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Baker McKenzie focuses on M&A, IP and regulatory work for clients such as Walgreens Boots Alliance and Novartis. Transactions expert Hiroshi Sheraton leads the team and advised Basilea on its licensing agreement with Pfizer for the rights to anti-fungal drug Cresemba. Jane Hobson also focuses on transactions and recently assisted ICU with its $900m purchase of Hospira. Product liability specialist John Leadley defended Bard against claims of allegedly faulty medical devices and procedures used to treat female pelvic organ prolapse and stress urinary incontinence. Other noteworthy names include Joanna Ludlam, who is an expert in public procurement; commercial agreements expert Duncan Reid-Thomas; and senior associate Julia Gillert, who is an expert in regulatory and compliance issues.

[back to top]


Back to index

Legal Developments by:
Baker McKenzie LLP

  • The New Turkish Code of Obligations: Important Changes for Leases of Residential & Business Premises

    For decades, the primary Turkish laws governing leases of residential and business premises have been the Law on Leasing Real Property dated May 27, 1955 (the ‚ÄúLease Law‚ÄĚ) and the Turkish Code of Obligations No. 818 dated April 22, 1926 (the ‚ÄúObligations Code‚ÄĚ). Both of these laws, however, will be repealed and replaced with the new Turkish Code of Obligations No. 6098 dated January 11, 2011 (the ‚ÄúNew Obligations Code‚ÄĚ), which will enter into force on July 7, 2012.
    - Esin Attorney Partnership

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to